glp-1 bmi 25 A new Penn Medicine study is drawing attention after researchers found that women taking medications had lower odds of developing breast cancer compared to women who were not taking the drugs 🚨 GLP-1 RA use in

minimal human data

They should not be used solely for chronic pain outside established indications

There is one important protection worth noting: "If you are not a candidate or approved for GLP-1 medication, your subscription will be cancelled, and we will work with you to find another solution." The company also states elsewhere that "if not deemed appropriate, you will be immediately refunded." The practical takeaway: the billing structure is quarterly, cancellation is available but fees already paid are described as non-refundable, and there is a minimum commitment period described in the terms

[DOI] [PubMed] [Google Scholar] 100.Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, et al

For health system leaders, clinicians, and Medicare administrators, the announcement raises important questions about access, pricing stability, and the future role of telehealth in obesity care

GLP-1 agonists particularly benefit from consistent weekly dosing